The Short Answer
Driven by dihydrotestosterone (DHT) gradually shrinking scalp hair follicles at the temples, crown, or center part. Starting topical or low-dose oral Minoxidil alongside a 5-alpha-reductase blocker (Finasteride or Dutasteride) and checking serum Ferritin (>50 ng/mL) and Vitamin D halts shedding over 3-6 months. Under the surface, Type II 5-alpha-reductase converts testosterone into high-affinity DHT within dermal papilla cells, shortening the anagen growth phase, prolonging kenogen latency, and inducing perifollicular micro-inflammation. [1][2].
Hearing or reading "Male & Female Pattern Hair Loss (Androgenetic Alopecia)" (coded in medical charts as ICD-10-CM L64.9, and also known as Androgenetic Alopecia, Male Pattern Baldness, Female Pattern Hair Thinning, DHT Follicular Miniaturization) can feel intimidating when a clinician only has 7 minutes to explain it. In plain kitchen-table terms, Driven by dihydrotestosterone (DHT) gradually shrinking scalp hair follicles at the temples, crown, or center part. Starting topical or low-dose oral Minoxidil alongside a 5-alpha-reductase blocker (Finasteride or Dutasteride) and checking serum Ferritin (>50 ng/mL) and Vitamin D halts shedding over 3-6 months. [1].
Physiologically, Type II 5-alpha-reductase converts testosterone into high-affinity DHT within dermal papilla cells, shortening the anagen growth phase, prolonging kenogen latency, and inducing perifollicular micro-inflammation. [2]. Understanding that root mechanism takes the mystery out of your diagnosis and shows you exactly why targeted daily steps and evidence-based treatments work [2][3].